Poisoning with 1-propanol and 2-propanol. 2007

M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
Department of Internal Medicine, Topolsica Hospital, Topolsica, Slovenia.

1-Propanol and 2-propanol are isomers of an alcohol with three carbons. They are colorless liquids with a sweet odor. 1-Propanol is metabolized by alcohol dehydrogenase to propionic acid and presents with metabolic acidosis and elevated anion gap, whereas 2-propanol is metabolized by alcohol dehydrogenase to acetone and presents with rapidly developing (within 3-4 h after exposure) ketosis and ketonuria but without metabolic acidosis. We report a patient who simultaneously ingested a lethal dose of 1-propanol and 2-propanol as a hand disinfectant in hospital. The patient lost consciousness and stopped breathing within half an hour after ingestion. He was intubated and artificially ventilated. Initial laboratory results showed mixed acidosis with elevated anion gap, but ketonuria appeared only 12 h after admission and 6 h following the regaining of consciousness. Therefore, laboratory results in simultaneous poisoning with two isomers of alcohol are not just a sum of laboratory results obtained in isolated poisoning with each isomer because they influence each other's metabolism: 1-propanol retards the metabolism of 2-propanol to acetone. In conclusion, 1-propanol and 2-propanol poisoning presents early with mixed acidosis and elevated anion gap and only later with ketonuria.

UI MeSH Term Description Entries
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D008297 Male Males
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000136 Acid-Base Equilibrium The balance between acids and bases in the BODY FLUIDS. The pH (HYDROGEN-ION CONCENTRATION) of the arterial BLOOD provides an index for the total body acid-base balance. Anion Gap,Acid-Base Balance,Acid Base Balance,Acid Base Equilibrium,Anion Gaps,Balance, Acid-Base,Equilibrium, Acid-Base,Gap, Anion,Gaps, Anion
D000142 Acidosis, Respiratory Respiratory retention of carbon dioxide. It may be chronic or acute. Respiratory Acidosis,Acidoses, Respiratory,Respiratory Acidoses
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000433 1-Propanol A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate. Alcohol, Propyl,Propanol,n-Propanol,Propyl Alcohol
D000681 Amylases A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. Diastase,Amylase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
January 1989, Zeitschrift fur Rechtsmedizin. Journal of legal medicine,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
February 1997, Environmental health perspectives,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
October 2007, The Journal of chemical physics,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
June 1988, Acta crystallographica. Section C, Crystal structure communications,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
October 2013, The journal of physical chemistry. A,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
February 2019, Neurocritical care,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
March 1949, The Journal of organic chemistry,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
January 1986, Polish journal of pharmacology and pharmacy,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
January 2012, The Journal of chemical physics,
M Vujasinovic, and M Kocar, and K Kramer, and M Bunc, and M Brvar
October 1960, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!